Axogen, Inc. Common Stock
AXGN Real Time Price USDRecent trades of AXGN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by AXGN's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$15,000 May 06, 2025 Issue: Health Issues
-
$15,000 Feb 04, 2025 Issue: Health Issues
-
$10,000 Nov 06, 2024 Issue: Health Issues
-
$10,000 Aug 08, 2024 Issue: Health Issues
-
$10,000 May 06, 2024 Issue: Health Issues
-
$10,000 Feb 05, 2024 Issue: Health Issues
-
$10,000 Nov 14, 2023 Issue: Health Issues
-
$10,000 Aug 07, 2023 Issue: Health Issues
-
$10,000 Feb 09, 2023 Issue: Health Issues
-
$10,000 Nov 06, 2022 Issue: Health Issues
-
$10,000 Jul 18, 2022 Issue: Health Issues
-
$10,000 May 25, 2022 Issue: Health Issues
-
$30,000 Jan 19, 2011 Issue: Medical/Disease Research/Clinical Labs
-
$36,000 Oct 16, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$36,000 Jul 14, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$12,000 Apr 18, 2010 Issue: Medical/Disease Research/Clinical Labs
Estimated quarterly lobbying spending
AXGN Revenue by Segment or Geography
New patents grants
-
Patent Title: Amnion tissue grafts and methods of preparing and using same Apr. 01, 2025
-
Patent Title: Connector and wrap for end-to-side nerve coaptation Feb. 25, 2025
-
Patent Title: Tissue-processing container for automated processing of tissue, methods of use thereof, and systems comprising the same Feb. 04, 2025
-
Patent Title: Packaging for wet tissue storage Dec. 10, 2024
-
Patent Title: Wet preservation of tissue Dec. 03, 2024
-
Patent Title: Fasciculated nerve grafts, methods of making the same, and methods of treatment using the same Jun. 04, 2024
-
Patent Title: Tissue grafts with pre-made attachment points May. 14, 2024
-
Patent Title: Organotypic drg-peripheral nerve culture system Apr. 16, 2024
-
Patent Title: Tissue-processing container for automated processing of tissue, methods of use thereof, and systems comprising the same Mar. 19, 2024
-
Patent Title: Organotypic drg-peripheral nerve culture system Jan. 30, 2024
-
Patent Title: Quantitative structural assay of a nerve graft Dec. 19, 2023
-
Patent Title: Wet preservation of tissue Aug. 29, 2023
-
Patent Title: Implant devices with a pre-set pulley system Feb. 28, 2023
-
Patent Title: Amnion tissue grafts and methods of preparing and using same Feb. 14, 2023
-
Patent Title: Wet preservation of tissue Dec. 13, 2022
-
Patent Title: Nerve culture system Nov. 29, 2022
-
Patent Title: Capture-tool for manipulating and entubulating nerves Jul. 12, 2022
-
Patent Title: Tissue grafts with pre-made attachment points Nov. 09, 2021
-
Patent Title: Organotypic drg-peripheral nerve culture system Oct. 26, 2021
-
Patent Title: Devices and methods for protecting against neuromas Oct. 19, 2021
-
Patent Title: Materials and methods for nerve repair with animal-sourced grafts Oct. 19, 2021
-
Patent Title: Materials and methods for protecting against neuromas Mar. 23, 2021
-
Patent Title: Materials and methods for protecting against neuromas Mar. 16, 2021
-
Patent Title: Implant devices with a pre-set pulley system Mar. 16, 2021
-
Patent Title: Connector and wrap for end-to-side nerve coaptation Nov. 17, 2020
-
Patent Title: Materials and methods for breast neurotization with nerve grafts Oct. 27, 2020
-
Patent Title: Quantitative structural assay of a nerve graft Sep. 22, 2020
-
Patent Title: Surgical tool for tissue sizing and transection Oct. 15, 2019
-
Patent Title: Capture-tool for manipulating and entubulating nerves Jul. 09, 2019
-
Patent Title: Quantitative structural assay of a nerve graft Jun. 04, 2019
-
Patent Title: Quantitative structural assay of a nerve graft Jun. 12, 2018
-
Patent Title: Quantitative structural assay of a nerve graft Jun. 27, 2017
-
Patent Title: Materials and methods for protecting against neuromas Apr. 25, 2017
-
Patent Title: Two-point discriminator sensory measurement device Jan. 31, 2017
-
Patent Title: Nerve elevator and method of use Oct. 01, 2013
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to AXGN
Recent picks made for AXGN stock on CNBC
ETFs with the largest estimated holdings in AXGN
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $AXGN stock a Buy, Sell, or Hold?
- What is the price target for $AXGN stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $AXGN stock?
- Who owns the most shares of $AXGN stock?
- What funds own $AXGN stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AXGN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.